GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
GRAIL (NASDAQ:GRAL), a healthcare company focused on early cancer detection, has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The company's management will deliver their presentation on Tuesday, September 9 at 1:50 p.m. ET.
Investors can access both the live presentation and replay through GRAIL's investor relations website at investors.grail.com. The webcast recording will remain available for a minimum of 30 days following the event.
GRAIL (NASDAQ:GRAL), azienda sanitaria specializzata nella diagnosi precoce del cancro, parteciper脿 al Morgan Stanley 23rd Annual Global Healthcare Conference. La direzione terr脿 la presentazione marted矛 9 settembre alle 13:50 ET.
Gli investitori potranno seguire la presentazione in diretta e rivederla sul sito delle relazioni con gli investitori di GRAIL all'indirizzo investors.grail.com. La registrazione webcast sar脿 disponibile per almeno 30 giorni dopo l'evento.
GRAIL (NASDAQ:GRAL), una compa帽铆a de salud centrada en la detecci贸n temprana del c谩ncer, ha anunciado su participaci贸n en el Morgan Stanley 23rd Annual Global Healthcare Conference. La direcci贸n ofrecer谩 su presentaci贸n el martes 9 de septiembre a las 1:50 p.m. ET.
Los inversores podr谩n acceder a la transmisi贸n en vivo y a la repetici贸n a trav茅s del sitio de relaciones con inversores de GRAIL en investors.grail.com. La grabaci贸n del webcast permanecer谩 disponible al menos 30 d铆as tras el evento.
GRAIL (NASDAQ:GRAL)鞚� 臁瓣赴 鞎� 歆勲嫧鞐� 欤茧牓頃橂姅 鞚橂 旮办梾鞙茧, Morgan Stanley 23rd Annual Global Healthcare Conference鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓 瓴届榿歆勳潣 氚滍憸電� 順勳鞁滉皠 頇旍殧鞚�, 9鞗� 9鞚� 鞓ろ泟 1鞁� 50攵�(ET)鞐� 歆勴枆霅╇媹雼�.
韴瀽鞛愲摛鞚� GRAIL鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼 investors.grail.com鞐愳劀 霛检澊敫� 頂勲爤鞝犿厡鞚挫厴瓿� 雼れ嫓氤搓赴毳� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟. 鞗轨簮鞀ろ姼 雲鬼檾電� 頄夓偓 膦呺 頉� 斓滌唽 30鞚� 霃欖晥 鞝滉车霅╇媹雼�.
GRAIL (NASDAQ:GRAL), entreprise de sant茅 sp茅cialis茅e dans la d茅tection pr茅coce du cancer, a annonc茅 sa participation 脿 la Morgan Stanley 23rd Annual Global Healthcare Conference. La direction pr茅sentera son expos茅 le mardi 9 septembre 脿 13h50 (ET).
Les investisseurs pourront acc茅der 脿 la pr茅sentation en direct et au replay via le site des relations investisseurs de GRAIL 脿 l'adresse investors.grail.com. L'enregistrement du webcast restera disponible au minimum 30 jours apr猫s l'茅v茅nement.
GRAIL (NASDAQ:GRAL), ein Gesundheitsunternehmen, das sich auf die Fr眉herkennung von Krebs spezialisiert hat, hat seine Teilnahme an der Morgan Stanley 23rd Annual Global Healthcare Conference angek眉ndigt. Das Management wird seine Pr盲sentation am Dienstag, 9. September um 13:50 Uhr ET halten.
Investoren k枚nnen die Live-Pr盲sentation und die Aufzeichnung auf der Investor-Relations-Website von GRAIL unter investors.grail.com abrufen. Die Webcast-Aufzeichnung wird mindestens 30 Tage nach der Veranstaltung verf眉gbar sein.
- None.
- None.
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at . The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit .
View original content to download multimedia:
SOURCE GRAIL, Inc.
FAQ
When is GRAIL (GRAL) presenting at the Morgan Stanley Healthcare Conference 2025?
How can investors watch GRAIL's Morgan Stanley conference presentation?
How long will GRAIL's Morgan Stanley conference presentation be available for replay?
What is GRAIL's main business focus?
